Tapewire

Nasdaq · USD

IRON

Disc Medicine, Inc.

Export transactions ↓
Tapewire entity
2273
SEC CIK
0001816736
Parsed reports
281

Last 12 months

Inside the activity.

0 purchase rows · 91 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 2025029
Jan 202604
Feb 202609
Mar 202602
Apr 202604
May 202600
Jun 2026012
Jul 202604
Aug 202607
Sep 2026016
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 07, 2026 Filed Jul 9, 2026 23:35 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 100 $13.50 $1,350.00
Disclosure

SEC source: 0001193125-26-299954 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 21:49 UTC
Khara RahulChief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,649 $0.00 Strike: $14.69 $0.00
Disclosure

SEC source: 0001193125-26-290902 · ownership.xml · derivative · entry 6

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,804

Underlying: Common Stock · 1,649 shares

Expires 2032-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 21:49 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 1,649 $75.00 $123,675.00
Disclosure

SEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 4

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,173

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 21:49 UTC
Khara RahulChief Legal Officer
Exercise / conversionCommon Stock 1,649 $14.69 $24,223.81
Disclosure

SEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 3

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 21:45 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 300 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-290891 · ownership.xml · derivative · entry 3

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,847

Underlying: Common Stock · 300 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 21:45 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 300 $72.50 $21,750.00
Disclosure

SEC source: 0001193125-26-290891 · ownership.xml · nonDerivative · entry 2

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 21:45 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 300 $13.50 $4,050.00
Disclosure

SEC source: 0001193125-26-290891 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 21:49 UTC
Khara RahulChief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 851 $0.00 Strike: $14.69 $0.00
Disclosure

SEC source: 0001193125-26-290902 · ownership.xml · derivative · entry 5

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,453

Underlying: Common Stock · 851 shares

Expires 2032-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 21:49 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 851 $75.00 $63,825.00
Disclosure

SEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 2

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,173

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 21:49 UTC
Khara RahulChief Legal Officer
Exercise / conversionCommon Stock 851 $14.69 $12,501.19
Disclosure

SEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 1

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

Read SEC document
June 22, 2026 Filed Jun 25, 2026 00:34 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 9,700 $0.00 Strike: $13.50 $0.00
Disclosure

SEC source: 0001193125-26-281519 · ownership.xml · derivative · entry 3

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,147

Underlying: Common Stock · 9,700 shares

Expires 2032-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F3 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
June 22, 2026 Filed Jun 25, 2026 00:34 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 9,700 $72.66 $704,795.21
Disclosure

SEC source: 0001193125-26-281519 · ownership.xml · nonDerivative · entry 2

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.50 to $72.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 22, 2026 Filed Jun 25, 2026 00:34 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 9,700 $13.50 $130,950.00
Disclosure

SEC source: 0001193125-26-281519 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:16 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 34,000 $0.00 Strike: $9.86 $0.00
Disclosure

SEC source: 0001193125-26-279779 · ownership.xml · derivative · entry 5

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,375

Underlying: Common Stock · 34,000 shares

Expires 2031-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F5 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:16 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 1,551 $71.61 $111,071.14
Disclosure

SEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 4

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 226,064

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.36 to $71.85, inclusive.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:16 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 9,522 $70.70 $673,205.40
Disclosure

SEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 3

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 227,615

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.36 to $71.35, inclusive.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:16 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 22,927 $69.92 $1,603,019.16
Disclosure

SEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 2

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 237,137

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:16 UTC
Quisel John DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 34,000 $9.86 $335,240.00
Disclosure

SEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 1

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:21 UTC
Khara RahulChief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $14.69 $0.00
Disclosure

SEC source: 0001193125-26-279792 · ownership.xml · derivative · entry 5

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,304

Underlying: Common Stock · 7,500 shares

Expires 2032-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F5 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:21 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 500 $71.62 $35,811.00
Disclosure

SEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 4

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,173

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.45 to $71.81, inclusive.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:21 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 1,600 $70.73 $113,161.12
Disclosure

SEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 3

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,673

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $71.38, inclusive.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:21 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 5,400 $69.94 $377,688.42
Disclosure

SEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 2

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,273

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:21 UTC
Khara RahulChief Legal Officer
Exercise / conversionCommon Stock 7,500 $14.69 $110,175.00
Disclosure

SEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 1

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,673

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:59 UTC GrantStock Option (Right to Buy) · Derivative 6,212 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279712 · ownership.xml · derivative · entry 1

GEMAYEL GEORGES · CIK 0001256088 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212

Underlying: Common Stock · 6,212 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:04 UTC GrantStock Option (Right to Buy) · Derivative 6,212 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279742 · ownership.xml · derivative · entry 1

White William Richard · CIK 0001778739 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212

Underlying: Common Stock · 6,212 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:01 UTC GrantStock Option (Right to Buy) · Derivative 6,212 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279734 · ownership.xml · derivative · entry 1

Ratcliffe Liam · CIK 0001547100 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212

Underlying: Common Stock · 6,212 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 21:00 UTC GrantStock Option (Right to Buy) · Derivative 6,212 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279732 · ownership.xml · derivative · entry 1

Nicholson Donald William · CIK 0001814617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212

Underlying: Common Stock · 6,212 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:58 UTC
Chin MarkDirector
GrantStock Option (Right to Buy) · Derivative 6,212 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279708 · ownership.xml · derivative · entry 1

Chin Mark · CIK 0001734389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212

Underlying: Common Stock · 6,212 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:56 UTC GrantStock Option (Right to Buy) · Derivative 6,212 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279705 · ownership.xml · derivative · entry 1

Bitterman Kevin · CIK 0001591747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212

Underlying: Common Stock · 6,212 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

F2 · ownership.direct: This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:54 UTC
AHMED NADIMDirector
GrantStock Option (Right to Buy) · Derivative 5,176 $0.00 Strike: $70.79 $0.00
Disclosure

SEC source: 0001193125-26-279690 · ownership.xml · derivative · entry 1

AHMED NADIM · CIK 0001731193 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,176

Underlying: Common Stock · 5,176 shares

Expires 2036-06-17

F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:43 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 13,351 $0.00 Strike: $9.86 $0.00
Disclosure

SEC source: 0001193125-26-275996 · ownership.xml · derivative · entry 6

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,951

Underlying: Common Stock · 13,351 shares

Expires 2031-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:43 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,261 $0.00 Strike: $9.86 $0.00
Disclosure

SEC source: 0001193125-26-275996 · ownership.xml · derivative · entry 5

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,753

Underlying: Common Stock · 5,261 shares

Expires 2031-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:43 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 6,961 $69.92 $486,699.20
Disclosure

SEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 4

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.40 to $70.19, inclusive.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:43 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 11,651 $68.76 $801,101.79
Disclosure

SEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 3

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,285

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.37 to $69.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:43 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 13,351 $9.86 $131,640.86
Disclosure

SEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 2

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,936

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:43 UTC
Yu Jonathan Yen-WenChief Operating Officer
Exercise / conversionCommon Stock 5,261 $9.86 $51,873.46
Disclosure

SEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026.

Read SEC document
April 14, 2026 Filed Apr 15, 2026 20:53 UTC
Franchi Jean M.Chief Financial Officer
SaleCommon Stock 6,257 $69.24 $433,234.05
Disclosure

SEC source: 0001193125-26-157187 · ownership.xml · nonDerivative · entry 2

Franchi Jean M. · CIK 0001653053 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,333

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $69.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 13, 2026 Filed Apr 15, 2026 21:05 UTC
Savage William JacobChief Medical Officer
SaleCommon Stock 2,200 $66.81 $146,976.06
Disclosure

SEC source: 0001193125-26-157215 · ownership.xml · nonDerivative · entry 2

Savage William Jacob · CIK 0001951852 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,480

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive.

Read SEC document
April 13, 2026 Filed Apr 15, 2026 21:05 UTC
Savage William JacobChief Medical Officer
SaleCommon Stock 3,531 $66.12 $233,472.90
Disclosure

SEC source: 0001193125-26-157215 · ownership.xml · nonDerivative · entry 1

Savage William Jacob · CIK 0001951852 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,680

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
April 13, 2026 Filed Apr 15, 2026 20:53 UTC
Franchi Jean M.Chief Financial Officer
SaleCommon Stock 400 $69.00 $27,600.00
Disclosure

SEC source: 0001193125-26-157187 · ownership.xml · nonDerivative · entry 1

Franchi Jean M. · CIK 0001653053 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,590

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:55 UTC
Savage William JacobChief Medical Officer
SaleCommon Stock 2,986 $66.41 $198,297.27
Disclosure

SEC source: 0001193125-26-091757 · ownership.xml · nonDerivative · entry 2

Savage William Jacob · CIK 0001951852 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,211

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.03 to $66.88, inclusive.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:55 UTC
Savage William JacobChief Medical Officer
SaleCommon Stock 4,392 $65.52 $287,771.75
Disclosure

SEC source: 0001193125-26-091757 · ownership.xml · nonDerivative · entry 1

Savage William Jacob · CIK 0001951852 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,197

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:49 UTC
Franchi Jean M.Chief Financial Officer
SaleCommon Stock 353 $69.06 $24,377.09
Disclosure

SEC source: 0001193125-26-083027 · ownership.xml · nonDerivative · entry 1

Franchi Jean M. · CIK 0001653053 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,990

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 22:42 UTC
Franchi Jean M.Chief Financial Officer
SaleCommon Stock 3,684 $65.89 $242,734.71
Disclosure

SEC source: 0001193125-26-059760 · ownership.xml · nonDerivative · entry 3

Franchi Jean M. · CIK 0001653053 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,343

F2 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.51 to $66.38, inclusive.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 22:42 UTC
Franchi Jean M.Chief Financial Officer
SaleCommon Stock 3,397 $65.01 $220,837.95
Disclosure

SEC source: 0001193125-26-059760 · ownership.xml · nonDerivative · entry 2

Franchi Jean M. · CIK 0001653053 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,027

F2 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.47 to $65.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 02:20 UTC
Khara RahulChief Legal Officer
SaleCommon Stock 2,853 $62.86 $179,339.58
Disclosure

SEC source: 0001193125-26-055652 · ownership.xml · nonDerivative · entry 1

Khara Rahul · CIK 0001951850 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,173

F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 02:09 UTC
Savage William JacobChief Medical Officer
SaleCommon Stock 3,256 $62.86 $204,672.16
Disclosure

SEC source: 0001193125-26-055630 · ownership.xml · nonDerivative · entry 1

Savage William Jacob · CIK 0001951852 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,589

F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 02:15 UTC
Stephenson PamelaChief Commercial Officer
SaleCommon Stock 5,531 $62.86 $347,678.66
Disclosure

SEC source: 0001193125-26-055646 · ownership.xml · nonDerivative · entry 1

Stephenson Pamela · CIK 0001767650 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,998

F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 02:05 UTC
Yu Jonathan Yen-WenChief Operating Officer
SaleCommon Stock 3,231 $62.86 $203,100.66
Disclosure

SEC source: 0001193125-26-055626 · ownership.xml · nonDerivative · entry 1

Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,324

F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 02:03 UTC
Quisel John DDirector · Chief Executive Officer
SaleCommon Stock 13,264 $62.86 $833,775.04
Disclosure

SEC source: 0001193125-26-055623 · ownership.xml · nonDerivative · entry 1

Quisel John D · CIK 0001586788 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 226,064

F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.